U.S FDA Names 14 More Chinese Heparin Suppliers Put On Alert List
This article was originally published in PharmAsia News
Fourteen Chinese makers of heparin, an anticoagulant linked with 80 U.S. deaths four years ago, have been identified by U.S. FDA, which placed them on an alert list for imported drugs.
You may also be interested in...
Artificial intelligence (AI) and machine learning took center stage at this year’s Radiological Society of North America meeting in Chicago, but the pervasiveness of AI tech in new product launches was further emphasized at the RSNA’s expanded AI Showcase exhibit.
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.